Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-08-14

Clinical Trial Update: Cardiac Evaluation in Hereditary Hemorrhagic Telangiectasia

View source ↗

Summary

A clinical trial update describes a planned cardiac evaluation in patients with Hereditary Hemorrhagic Telangiectasia, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hereditary Hemorrhagic Telangiectasia | Status: NOT_YET_RECRUITING